Feb 28,2023 Aravive Announces FDA Orphan Drug Designation Granted to Batiraxcept for the Treatment of Pancreatic Cancer read more >>
Feb 14,2023 Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin read more >>
Feb 10,2023 Cognition Therapeutics Completes Enrollment of CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease read more >>
Jan 31,2023 C4 Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating CFT1946, an Orally Bioavailable BiDAC™ Degrader, in BRAF V600 Mutant Solid Tumors read more >>
Jan 27,2023 Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Factory of the Future read more >>
Jan 05,2023 Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million read more >>